McDonald’s is about to report earnings. Here’s what to expect

McDonald’s is about to report earnings. Here’s what to expect


The logo of McDonald’s is seen in Los Angeles, California.

Lucy Nicholson | Reuters

McDonald’s is expected to report its third-quarter earnings before the bell on Wednesday.

Here’s what Wall Street analysts surveyed by LSEG are expecting the company to report:

  • Earnings per share: $3.33 expected
  • Revenue: $7.1 billion expected

The fast-food giant, often seen as a bellwether for the financial health of consumers, has spent more than a year sounding the alarm about a pullback in spending from low-income diners. But Wall Street is anticipating that McDonald’s will report same-store sales growth for the second straight quarter, showing that its value strategy is winning over customers.

Kicking off the third quarter, McDonald’s Snack Wraps returned to menus for the first time in nine years. And in September, the chain brought back Extra Value Meals, which it last promoted before the Covid-19 pandemic.

Analysts are projecting that McDonald’s will report global same-store sales growth of 3.5%, according to StreetAccount estimates. Wall Street expects that the burger chain’s international markets will outperform the U.S., where same-store sales are projected to grow 1.9%.

McDonald’s stock has risen just 3% this year, as investor concerns about the restaurant industry and the broader economy have weighed on shares. The company has a market cap of more than $212 billion.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More